Regulation of the pehA gene encoding the major polygalacturonase of Xanthomonas campestris by CIp and RpfF

[[abstract]]Exopolysaccharide and several extracellular enzymes of Xanthomonas campestris pv. campestris (Xcc), the causative agent of black rot in crucifers, are virulence factors. In this study, sequence and mutational analysis has demonstrated that Xcc pehA encodes the major polygalacturonase, a member of family 28 of the glycosyl hydrolases. Using the 5' RACE (rapid amplification of cDNA ends) method, the pehA transcription initiation site was mapped at 102 nt downstream of a CIp (cAMP receptor protein-like protein)-binding site. Transcriptional fusion assays showed that pehA transcription is greatly induced by polygalacturonic acid, positively regulated by CIp and RpfF (an enoyl-CoA hydratase homologue which is required for the synthesis of cis-11-methyl-2-dodecenoic acid, a low-molecular-mass diffusible signal factor), subjected to catabolite repression, which is independent of CIp or RpfF, and repressed under conditions of oxygen limitation or nitrogen starvation. Our findings extend previous work on CIp and RpfF regulation to show that they both influence the expression of pehA in Xcc

Regulation of the pehA Gene Encoding the Major Polygalacturonase of Xanthomonas campestris by Clp and RpfF

[[abstract]]Exopolysaccharide and several extracellular enzymes of Xanthomonas campestris pv. campestris (Xcc), the causative agent of black rot in crucifers, are virulence factors. In this study, sequence and mutational analysis has demonstrated that Xcc pehA encodes the major polygalacturonase, a member of family 28 of the glycosyl hydrolases. Using the 5' RACE (rapid amplification of cDNA ends) method, the pehA transcription initiation site was mapped at 102 nt downstream of a Clp (cAMP receptor protein-like protein)-binding site. Transcriptional fusion assays showed that pehA transcription is greatly induced by polygalacturonic acid, positively regulated by Clp and RpfF (an enoyl-CoA hydratase homologue which is required for the synthesis of cis-11-methyl-2-dodecenoic acid, a low-molecular-mass diffusible signal factor), subjected to catabolite repression, which is independent of Clp or RpfF, and repressed under conditions of oxygen limitation or nitrogen starvation. Our findings extend previous work on Clp and RpfF regulation to show that they both influence the expression of pehA in Xcc

Improving Automatic Jazz Melody Generation by Transfer Learning Techniques

In this paper, we tackle the problem of transfer learning for Jazz automatic generation. Jazz is one of representative types of music, but the lack of Jazz data in the MIDI format hinders the construction of a generative model for Jazz. Transfer learning is an approach aiming to solve the problem of data insufficiency, so as to transfer the common feature from one domain to another. In view of its success in other machine learning problems, we investigate whether, and how much, it can help improve automatic music generation for under-resourced musical genres. Specifically, we use a recurrent variational autoencoder as the generative model, and use a genre-unspecified dataset as the source dataset and a Jazz-only dataset as the target dataset. Two transfer learning methods are evaluated using six levels of source-to-target data ratios. The first method is to train the model on the source dataset, and then fine-tune the resulting model parameters on the target dataset. The second method is to train the model on both the source and target datasets at the same time, but add genre labels to the latent vectors and use a genre classifier to improve Jazz generation. The evaluation results show that the second method seems to perform better overall, but it cannot take full advantage of the genre-unspecified dataset.Comment: 8 pages, Accepted to APSIPA ASC(Asia-Pacific Signal and Information Processing Association Annual Summit and Conference ) 201

Novel microinjector for carrying bone substitutes for bone regeneration in periodontal diseases

Background/PurposeTraditionally, guide bone regeneration (GBR) was a widely used method for repairing bone lost from periodontal disease. There were some disadvantages associated with the GBR method, such as the need for a stable barrier membrane and a new creative cavity during the surgical process. To address these disadvantages, the purpose of this study was to evaluate a novel microinjector developed for dental applications. The microinjector was designed to carry bone graft substitutes to restore bone defects for bone regeneration in periodontal diseases. The device would be used to replace the GBR method.MethodsIn this study, the injected force and ejected volume of substitutes (including air, water, and ethanol) were defined by Hooke's law (n = 3). The optimal particle size of bone graft substitutes was determined by measuring the recycle ratio of bone graft substitutes from the microinjector (n = 3). Furthermore, a novel agarose gel model was used to evaluate the feasibility of the microinjector.ResultsThe current study found that the injected force was less than 0.4 N for obtaining the ejected volume of approximately 2 mL, and when the particle size of tricalcium phosphate (TCP) was smaller than 0.5 mm, 80% TCP could be ejected from the microinjector. Furthermore, by using an agarose model to simulate the periodontal soft tissue, it was also found that bone graft substitutes could be easily injected into the gel.ConclusionThe results confirmed the feasibility of this novel microinjector for dental applications to carry bone graft substitutes for the restoration of bone defects of periodontal disease

Applying Quantile Regression to Assess the Relationship between R&D, Technology Import and Patent Performance in Taiwan

[[abstract]]Electronics companies are facing global economic and trade competition. As patents can form an endowment shield that protects the development of corporate capabilities, companies are actively increasing their number of patents and attaching importance to technological research and development and patent management to achieve differentiated strategic effects. As such, patent layout and research and development (R&D) investment have become important strategic weapons for Taiwanese manufacturers, with which to enter the international market or compete among enterprises. This study first utilized the principal components analysis method to define patents in terms of the number of patents and the times patents are cited, with R&D defined in terms of expenditure and intensity. Furthermore, this study used a quantile regression model to visualize the relationship between R&D, technological imports, and patent performance in Taiwanese listed electronics companies. The empirical results show that technological imports in the second time-lag period require patents, while the effect on patents varies alongside industry characteristics. In addition, the empirical results found that the total assets, number of employees, and number of patent inventors are also factors that significantly affect patents. This research proposes that Taiwan’s listed electronics companies should expand their scale, increase their economic efficiency, maximize their resources, increase their patents, enhance their corporate value, boost their investor confidence, and improve their industry competitiveness.[[notice]]補正完

Frequency Dependent Alterations in Regional Homogeneity of Baseline Brain Activity in Schizophrenia

Low frequency oscillations are essential in cognitive function impairment in schizophrenia. While functional connectivity can reveal the synchronization between distant brain regions, the regional abnormalities in task-independent baseline brain activity are less clear, especially in specific frequency bands. Here, we used a regional homogeneity (ReHo) method combined with resting-state functional magnetic resonance imaging to investigate low frequency spontaneous neural activity in the three different frequency bands (slow-5:0.01–0.027 Hz; slow-4:0.027–0.08 Hz; and typical band: 0.01–0.08 Hz) in 69 patients with schizophrenia and 62 healthy controls. Compared with controls, schizophrenia patients exhibited decreased ReHo in the precentral gyrus, middle occipital gyrus, and posterior insula, whereas increased ReHo in the medial prefrontal cortex and anterior insula. Significant differences in ReHo between the two bands were found in fusiform gyrus and superior frontal gyrus (slow-4> slow-5), and in basal ganglia, parahippocampus, and dorsal middle prefrontal gyrus (slow-5> slow-4). Importantly, we identified significant interaction between frequency bands and groups in the inferior occipital gyrus and caudate body. This study demonstrates that ReHo changes in schizophrenia are widespread and frequency dependent

Identification of novel DNA methylation inhibitors via a two-component reporter gene system

<p>Abstract</p> <p>Background</p> <p>Targeting abnormal DNA methylation represents a therapeutically relevant strategy for cancer treatment as demonstrated by the US Food and Drug Administration approval of the DNA methyltransferase inhibitors azacytidine and 5-aza-2'-deoxycytidine for the treatment of myelodysplastic syndromes. But their use is associated with increased incidences of bone marrow suppression. Alternatively, procainamide has emerged as a potential DNA demethylating agent for clinical translation. While procainamide is much safer than 5-aza-2'-deoxycytidine, it requires high concentrations to be effective in DNA demethylation in suppressing cancer cell growth. Thus, our laboratories have embarked on the pharmacological exploitation of procainamide to develop potent DNA methylation inhibitors through lead optimization.</p> <p>Methods</p> <p>We report the use of a DNA methylation two-component enhanced green fluorescent protein reporter system as a screening platform to identify novel DNA methylation inhibitors from a compound library containing procainamide derivatives.</p> <p>Results</p> <p>A lead agent IM25, which exhibits substantially higher potency in <it>GSTp1 </it>DNA demethylation with lower cytotoxicity in MCF7 cells relative to procainamide and 5-aza-2'-deoxycytidine, was identified by the screening platform.</p> <p>Conclusions</p> <p>Our data provide a proof-of-concept that procainamide could be pharmacologically exploited to develop novel DNA methylation inhibitors, of which the translational potential in cancer therapy/prevention is currently under investigation.</p